Related Experiment Video

Updated: Aug 15, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

JAK protein kinase inhibitors

James E Thompson1

  • 1Department of Immunology and Rheumatology, Merck Research Laboratories, Rahway, New Jersey 07065, USA. Jed_thompson@merck.com

Drug News & Perspectives
|September 30, 2005
PubMed

Insights

Targeting Janus kinase 3 (JAK3) offers a promising therapeutic strategy for immunosuppression, particularly in preventing organ transplant rejection. JAK3 inhibition shows potential for treating specific conditions by modulating immune responses.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • The Janus protein tyrosine kinase (JAK) family, comprising JAK1, JAK2, JAK3, and TYK2, plays a crucial role in signal transduction.
  • JAKs mediate cellular signaling by phosphorylating signal transducers and activators of transcription (STATs).
  • Cellular mechanisms exist to inhibit JAK/STAT signaling, but therapeutic modulation remains an area of active research.

Purpose of the Study:

  • To explore the therapeutic potential of inhibiting specific JAK family members.
  • To evaluate the feasibility of targeting JAK kinase activity for positive therapeutic outcomes.
  • To investigate the specific roles of JAK family members in cellular signaling and disease.

Main Methods:

  • Analysis of existing data on JAK family member functions and inhibition.
  • Review of studies investigating the effects of JAK inhibition in various contexts.
  • Correlation of JAK family member expression and activity with specific physiological and pathological conditions.

Main Results:

  • Current data do not support therapeutic use for JAK1 and TYK2 inhibition.
  • JAK2 inhibition shows promise for leukemia treatment but requires further testing.
  • JAK3 inhibition presents a more promising therapeutic avenue, particularly for immunosuppression.

Conclusions:

  • JAK3 inhibition is a potential strategy for immunosuppressive therapies, such as preventing organ transplant rejection.
  • The specific role of JAK3 in the hematopoietic system and immune suppression makes it a key therapeutic target.
  • Further research is needed to fully realize the therapeutic potential of JAK inhibition, especially for JAK3.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...